BiomX Inc. (NYSE AMERICAN: PHGE) Stock Information | RedChip

BiomX Inc. (NYSE AMERICAN: PHGE)


$0.5700
+0.0006 ( +0.60% ) 43.9K

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

Market Data


Open


$0.5700

Previous close


$0.5694

Volume


43.9K

Market cap


$10.91M

Day range


$0.5680 - $0.6160

52 week range


$0.4800 - $8.5500

SEC Filings


Form Type Description Pages Date
3 Insider transactions 1 Mar 26, 2024
8-k/a 8K-related 14 Mar 21, 2024
3 Insider transactions 1 Mar 21, 2024
3 Insider transactions 1 Mar 21, 2024
3 Insider transactions 1 Mar 21, 2024
4 Insider transactions 1 Mar 19, 2024
3 Insider transactions 3 Mar 19, 2024
4 Insider transactions 2 Mar 19, 2024
8-k 8K-related 15 Mar 18, 2024
8-k 8K-related 62 Mar 06, 2024

Latest News